BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30191630)

  • 1. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
    Chang MM; Lai MS; Hong SY; Pan BS; Huang H; Yang SH; Wu CC; Sun HS; Chuang JI; Wang CY; Huang BM
    Cancer Sci; 2018 Nov; 109(11):3503-3518. PubMed ID: 30191630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Cancer Effect of Cordycepin on FGF9-Induced Testicular Tumorigenesis.
    Chang MM; Hong SY; Yang SH; Wu CC; Wang CY; Huang BM
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF9 promotes cell proliferation and tumorigenesis in TM3 mouse Leydig progenitor cells.
    Chang MM; Weng HY; Lai MS; Wang LW; Yang SH; Wu CC; Wang CY; Huang BM
    Am J Cancer Res; 2022; 12(12):5613-5630. PubMed ID: 36628285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy.
    Zhao X; Xu Y; Wu Y; Zhang H; Shi H; Zhu H; Woo M; Wu X
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E135-E144. PubMed ID: 30512986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
    Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.
    Li T; Xiong Y; Wang Q; Chen F; Zeng Y; Yu X; Wang Y; Zhou F; Zhou Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4001-4011. PubMed ID: 31588803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
    Alinari L; Prince CJ; Edwards RB; Towns WH; Mani R; Lehman A; Zhang X; Jarjoura D; Pan L; Kinghorn AD; Grever MR; Baiocchi RA; Lucas DM
    Clin Cancer Res; 2012 Sep; 18(17):4600-11. PubMed ID: 22791882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
    Hahm ER; Singh SV
    Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.
    Ramana KV; Tammali R; Srivastava SK
    Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide.
    Shi MD; Lin HH; Lee YC; Chao JK; Lin RA; Chen JH
    Chem Biol Interact; 2008 Aug; 174(3):201-10. PubMed ID: 18619950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells.
    Guo J; Sheng G; Warner BW
    J Biol Chem; 2005 Oct; 280(43):35992-8. PubMed ID: 16126730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
    Tyagi A; Agarwal C; Agarwal R
    Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of E2F1 transcriptional activity in cadmium-induced cell-cycle arrest at G1 in human lung fibroblasts.
    Choi YJ; Yin HQ; Suh HR; Lee YJ; Park SR; Lee BH
    Environ Mol Mutagen; 2011 Mar; 52(2):145-52. PubMed ID: 20839231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
    Whittaker SR; Walton MI; Garrett MD; Workman P
    Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.
    Madan E; Gogna R; Kuppusamy P; Bhatt M; Pati U; Mahdi AA
    Br J Cancer; 2012 Jul; 107(3):516-26. PubMed ID: 22782351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.